Amgen to open Hyderabad Science and Innovation Center in Genome Valley by 2027
Amgen is expanding its India presence with a new Science and Innovation Center in Hyderabad’s Genome Valley biopharma park, expected to open in 2027. The site will unite scientists working across discovery chemistry, drug metabolism and pharmacokinetics, and precision medicine. The move follows other R&D investments in Thousand Oaks and South San Francisco and adds to Amgen’s global lab network.